Akanda
AKAN | NASDAQ
$2.21
+$0.85 (+62.50%)
At close: Nov 16, 2026, 4:00 PM ET
$2.69
+$0.48 (+21.72%)
After-hours:
Nov 16, 2026, 7:59 PM ET
Akanda Company Profile
Company profile explainedCompany Profile
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Key Executives
| Name | Position |
|---|---|
| Christopher Robert Cooper | Chief Executive Officer & Director |
| Katharyn Field | Interim Chief Executive Officer & Executive Director |
| Gurcharn Deol | Chief Financial Officer |
| Edgar Contreras | Country Manager of First Towers |
| Francisco Juarez | VP, COO & Director of First Towers |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 22, 2026 | RW | Filing |
| Oct 19, 2026 | F-1/A | [Amend] Filing |
| Oct 01, 2026 | F-1 | Filing |
| Sep 30, 2026 | 6-K | Filing |
| Sep 25, 2026 | 6-K | Filing |
| Sep 09, 2026 | 6-K | Filing |
| Sep 04, 2026 | 6-K | Filing |
| Aug 17, 2026 | 6-K | Filing |
| Aug 13, 2026 | 6-K | Filing |
| Jun 18, 2026 | 6-K | Filing |
Akanda
| Country | Canada |
| IPO Date | Mar 15, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Christopher Robert Cooper |
Contact Details
100 King St. W Toronto,
ON M5X 1G5 Canada
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001888014 |
| CUSIP Number | 00971M700 |
| ISIN Number | CA00971M7008 |
| SIC Code | 2833 |
Add to Watchlist
Select watchlists to add or remove AKAN